Latest News

The biotechnology company AaviGen is providing €17 million in a second round of funding to advance precision gene therapies for heart failure into the clinic. In the context of cardiovascular translational research, the company emerged partly from DZHK-funded projects.

Read more

Cardiologist Felix Hohendanner is using artificially generated cells to determine the best possible individual therapy for new forms of "CPVT": a treacherous disease that is often responsible for sudden cardiac death in young people.

Read more

Around one third of people with heart disease suffer from sleep problems. In a paper published in the journal Science, a team at the Technical University of Munich (TUM) shows that heart diseases affect the production of the sleep hormone melatonin in the pineal gland. The link...

Read more

Research on Takotsubo syndrome, also known as broken heart syndrome / Heart researchers at Heidelberg University investigate an inflammatory signaling pathway in an animal model and show the damaging effect of stress hormones on the heart / In a newly established animal model of...

Read more

British and German scientists created the most comprehensive cell atlas of the human heart. As reported in the journal “Nature”, it is the first to include the cells from which the heartbeat originates. Among other things, this data will provide a reference for studies on cardiac...

Read more

Prof. Jeanette Erdmann passed away unexpectedly on 9 July 2023 at the age of 57 after a tragic fall. As the first DZHK professor, she had a major influence on the DZHK in Lübeck in particular. She was a great personality and will be missed - both professionally and personally.

Read more

For his achievements as a clinically active cardiologist and his scientific success in deciphering the genetic causes of heart attacks, Heribert Schunkert was awarded the Order of Merit by the Bavarian Minister-President on 5 July. Schunkert is Principal Investigator at the DZHK...

Read more

The European Molecular Biology Organization EMBO has elected Michael Potente, Principal Investigator at the DZHK partner site in Berlin, as a new member. He is joining a community of more than 2,000 leading life scientists in Europe and beyond. Potente is Professor for...

Read more

An interdisciplinary team of clinicians and scientists has published a consensus paper recommending appropriate quantitative imaging techniques for coronary artery stenosis and atherosclerosis related treatment and procedural planning.

Read more